Evidence map›Paper›PMID 36556141›Full record

ArticleJournal of clinical medicine2022

Analysis of

Mariam Moalla, Mouna Mnif-Feki, Wajdi Safi, Nadia Charfi, Nabila Mejdoub-Rekik, Mohamed Abid, Faten Hadj Kacem, Hassen Hadj Kacem

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Association of HomozygousMedicina (Kaunas, Lithuania) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mariam MoallaLaboratory of Molecular and Cellular Screening Processes, Center of Biotechnology of Sfax, Sfax 3018, Tunisia.
Mouna Mnif-FekiEndocrinology Department, Hedi Chaker Hospital, Sfax 3029, Tunisia.
Wajdi SafiEndocrinology Department, Hedi Chaker Hospital, Sfax 3029, Tunisia.
Nadia CharfiEndocrinology Department, Hedi Chaker Hospital, Sfax 3029, Tunisia.
Nabila Mejdoub-RekikEndocrinology Department, Hedi Chaker Hospital, Sfax 3029, Tunisia.
Mohamed AbidEndocrinology Department, Hedi Chaker Hospital, Sfax 3029, Tunisia.
Faten Hadj KacemEndocrinology Department, Hedi Chaker Hospital, Sfax 3029, Tunisia.
Hassen Hadj KacemDepartment of Applied Biology, College of Sciences, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates.ORCID 0000-0002-1884-2973
Hopital Universitaire Hedi Chaker · TNUniversity of Sfax · TNUniversity of Sharjah · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Non-syndromic combined pituitary hormone deficiency (CPHD) occurs due to defects in transcription factors that govern early pituitary development and the specification of hormone-producing cells. The most common mutations are in the Prophet of Pit-1 (ProP1) gene. This work aims to (1) report findings of genetic analyses of Tunisian patients with non-syndromic CPHD and (2) describe their phenotype patterns and their evolution through life. Methods: Fifteen patients from twelve unrelated families with variable clinical phenotypes were included after excluding autoimmune and acquired forms of non-syndromic CPHD. Detailed pedigree charts and auxological, hormonal, radiological, and therapeutic details were recorded. Sanger sequencing was performed, and sequences were analyzed with a specific focus on coding and splice site regions of the ProP1 gene. Retained variants were classified using several in silico pathogenicity prediction tools and the VarSome platform. Results: We identified the common p.Arg73Cys mutation in seven patients from four unrelated pedigrees. We found a novel homozygous mutation (c.340C>T) in one sporadic case. This mutation generates a truncated ProP1 protein, predicted to be non-functional, lacking the last 112 codons (p.(Gln114Ter)). We confirmed by polymerase chain reaction (PCR) the absence of large exon deletions or insertions in the remaining sporadic patients (7/8). Conclusions: We report two mutations {one newly identified [p.(Gln114Ter)] and one previously reported (p.Arg73Cys)} in five unrelated Tunisian families with non-syndromic CPHD. This work is of clinical importance as it reports the high frequency of the p.Arg73Cys mutation in Tunisian CPHD families. Our study also illuminated the involvement of novel gene(s) in the emergence of non-syndromic CPHD.

Indexed as

non-syndromic combined pituitary hormone deficiencyp.Arg73Cysp.(Gln114Ter)ProP1 geneSanger sequencing

Identifiers

PMID36556141
PMCPMC9787973
OpenAlexW4312211966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.